Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapies for rare diseases: therapeutic modalities, progress and challenges ahead
Erik Tambuyzer, Benjamin Vandendriessche, Christopher P. Austin, et al.
Nature Reviews Drug Discovery (2019) Vol. 19, Iss. 2, pp. 93-111
Open Access | Times Cited: 268

Showing 1-25 of 268 citing articles:

Overcoming cancer therapeutic bottleneck by drug repurposing
Zhe Zhang, Li Zhou, Na Xie, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 430
How many rare diseases are there?
Melissa Haendel, Nicole Vasilevsky, Deepak Unni, et al.
Nature Reviews Drug Discovery (2019) Vol. 19, Iss. 2, pp. 77-78
Open Access | Times Cited: 364
DrugCentral 2021 supports drug discovery and repositioning
Sorin Avram, Cristian Bologa, Jayme Holmes, et al.
Nucleic Acids Research (2020) Vol. 49, Iss. D1, pp. D1160-D1169
Open Access | Times Cited: 179
Advancing computer-aided drug discovery (CADD) by big data and data-driven machine learning modeling
Linlin Zhao, Heather L. Ciallella, Lauren M. Aleksunes, et al.
Drug Discovery Today (2020) Vol. 25, Iss. 9, pp. 1624-1638
Open Access | Times Cited: 175
Randomized Controlled Trials Versus Real World Evidence: Neither Magic Nor Myth
Hans‐Georg Eichler, Francesco Pignatti, Brigitte Schwarzer‐Daum, et al.
Clinical Pharmacology & Therapeutics (2020) Vol. 109, Iss. 5, pp. 1212-1218
Open Access | Times Cited: 143
Artificial intelligence-enabled fully automated detection of cardiac amyloidosis using electrocardiograms and echocardiograms
Shinichi Goto, Keitaro Mahara, Lauren Beussink‐Nelson, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 139
Deep learning for drug repurposing: Methods, databases, and applications
Xiaoqin Pan, Xuan Lin, Dongsheng Cao, et al.
Wiley Interdisciplinary Reviews Computational Molecular Science (2022) Vol. 12, Iss. 4
Open Access | Times Cited: 98
Genomic newborn screening for rare diseases
Zornitza Stark, Richard H. Scott
Nature Reviews Genetics (2023) Vol. 24, Iss. 11, pp. 755-766
Closed Access | Times Cited: 91
Artificial Intelligence for Drug Discovery: Are We There Yet?
Catrin Hasselgren, Tudor I. Oprea
The Annual Review of Pharmacology and Toxicology (2023) Vol. 64, Iss. 1, pp. 527-550
Open Access | Times Cited: 75
Rare molecular subtypes of lung cancer
Guilherme Harada, Soo‐Ryum Yang, Emiliano Cocco, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 4, pp. 229-249
Open Access | Times Cited: 73
The Impact of Artificial Intelligence in the Odyssey of Rare Diseases
Anna Visibelli, Bianca Roncaglia, Ottavia Spiga, et al.
Biomedicines (2023) Vol. 11, Iss. 3, pp. 887-887
Open Access | Times Cited: 51
Protein‐based Nanoparticles: From Drug Delivery to Imaging, Nanocatalysis and Protein Therapy
Jonas Kaltbeitzel, Peter Wich
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 44
Open Access | Times Cited: 50
Tribulations and future opportunities for artificial intelligence in precision medicine
Claudio Carini, Attila A. Seyhan
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 33
Drug repurposing for rare: progress and opportunities for the rare disease community
Anneliene Hechtelt Jonker, Daniel O’Connor, Maria Cavaller-Bellaubi, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 22
Establishing a second-generation artificial intelligence-based system for improving diagnosis, treatment, and monitoring of patients with rare diseases
Noa Hurvitz, Henny Azmanov, Asa Kesler, et al.
European Journal of Human Genetics (2021) Vol. 29, Iss. 10, pp. 1485-1490
Open Access | Times Cited: 68
Using four decades of FDA orphan drug designations to describe trends in rare disease drug development: substantial growth seen in development of drugs for rare oncologic, neurologic, and pediatric-onset diseases
Kathleen L. Miller, Lewis J. Fermaglich, Janet W. Maynard
Orphanet Journal of Rare Diseases (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 67
Approval success rates of drug candidates based on target, action, modality, application, and their combinations
Shingo Yamaguchi, Masayuki Kaneko, Mamoru Narukawa
Clinical and Translational Science (2021) Vol. 14, Iss. 3, pp. 1113-1122
Open Access | Times Cited: 66
Advancing translational science education
Jessica M. Faupel‐Badger, Amanda L. Vogel, Christopher P. Austin, et al.
Clinical and Translational Science (2022) Vol. 15, Iss. 11, pp. 2555-2566
Open Access | Times Cited: 59
DrugCentral 2023 extends human clinical data and integrates veterinary drugs
Sorin Avram, Thomas B. Wilson, Ramona Curpăn, et al.
Nucleic Acids Research (2022) Vol. 51, Iss. D1, pp. D1276-D1287
Open Access | Times Cited: 51
The Vascular Endothelium and Coagulation: Homeostasis, Disease, and Treatment, with a Focus on the Von Willebrand Factor and Factors VIII and V
Juan A. De Pablo-Moreno, Luis Javier Serrano, Luis Revuelta, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8283-8283
Open Access | Times Cited: 50
The Impact of Artificial Intelligence on Optimizing Diagnosis and Treatment Plans for Rare Genetic Disorders
Shenouda Abdallah, Mouhammad Sharifa, Mohammed Khaleel I Kh Almadhoun, et al.
Cureus (2023)
Open Access | Times Cited: 36
Clinical applications of gene therapy for rare diseases: A review
Ioannis Papaioannou, James S. Owen, Rafael J. Yáñez‐Muñoz
International Journal of Experimental Pathology (2023) Vol. 104, Iss. 4, pp. 154-176
Open Access | Times Cited: 32
Emerging roles and opportunities for rare disease patient advocacy groups
Amy M. Patterson, Megan O’Boyle, Grace E. VanNoy, et al.
Therapeutic Advances in Rare Disease (2023) Vol. 4
Open Access | Times Cited: 29
Ultrarapid‐Acting Microneedles for Immediate Delivery of Biotherapeutics
Jiahuan You, Changwei Yang, Jinpeng Han, et al.
Advanced Materials (2023) Vol. 35, Iss. 45
Closed Access | Times Cited: 28
Carbon Dots with Guanidinium and Amino Acid Functional Groups for Targeted Small Interfering RNA Delivery toward Tumor Gene Therapy
Huimin Xu, Jianqiao Chang, Hao Wu, et al.
Small (2023) Vol. 19, Iss. 31
Closed Access | Times Cited: 24
Page 1 - Next Page

Scroll to top